CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

Impact of Staging Percutaneous Coronary Intervention in Left Main Artery Disease: Insights From the EXCEL Trial Extracellular Vesicles From Epicardial Fat Facilitate Atrial Fibrillation Optical Coherence Tomography Guided Percutaneous Coronary Intervention With Nobori Stent Implantation in Patients With Non-ST-Segment-Elevation Myocardial Infarction (OCTACS) Trial: Difference in Strut Coverage and Dynamic Malapposition Patterns at 6 Months Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey Antiplatelet therapy in patients with myocardial infarction without obstructive coronary artery disease The optimal duration of dual antiplatelet therapy after coronary stent implantation: to go too far is as bad as to fall short A randomized comparison of Coronary Stents according to Short or Prolonged durations of Dual Antiplatelet Therapy in patients with Acute Coronary Syndromes: a pre-specified analysis of the SMART-DATE trial

Guideline2019 Jul 1;94(1):29-37.

JOURNAL:Catheter Cardiovasc Interv. Article Link

SCAI clinical expert consensus statement on the classification of cardiogenic shock: This document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019

DA Baran, CL Grines, S Bailey et al. Keywords: AMICS; SCAI

Full Text PDF